GlassScriptPhysician profile
Amanda D Murdock
NPI 1164610283
$3,204.70
in general payments reported to CMS, 2019-2025
40 companies · $473 in 2025
The $473 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $508 · 2021: $509 · 2022: $503 · 2023: $399 · 2024: $326 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $530.36 | 2019-2023 | |
| Daiichi Sankyo INC. | $516.97 | 2019-2025 | Injectafer |
| Astellas Pharma US INC | $448.35 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $421.88 | 2019-2025 | |
| Organon LLC | $150.72 | 2021-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $104.20 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $85.64 | 2024-2025 | Myfembree |
| Amgen INC. | $76.56 | 2020-2023 | Evenity, Prolia |
| Coopersurgical, INC. | $73.52 | 2023 | Advincula Delineator Uterine Manipulator |
| Baxter Healthcare | $67.37 | 2022-2025 | Perclot |
| Therapeuticsmd, INC. | $59.52 | 2019-2022 | |
| Lupin INC. | $53.97 | 2019-2020 | |
| Novo Nordisk INC | $53.93 | 2019-2021 | |
| Pfizer INC. | $48.53 | 2022-2025 | |
| Conmed Corporation | $32.58 | 2020 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Murdock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.